Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Strength
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Pack Size
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Form
Spikevax (previously COVID-19 Vaccine Moderna)-H/C/PSUSA/00010897/202212: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Source
European Medicines Agency
